Key facts
- This page summarizes Amy E. Herr's Form 3 filing for BIO-TECHNE Corp (TECH).
- 0 reported transactions and 9 derivative rows are listed below.
- Accepted by SEC: 07 Feb 2025, 16:55.
Amy E. Herr - 01 Feb 2025 Form 3 Insider Report for BIO-TECHNE Corp (TECH)
- Reporting relationship
- Director
- Issuer ticker
- TECH
- Reported as of
- 01 Feb 2025
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 07 Feb 2025, 16:55:32 UTC
- Next SEC filing
- 07 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- Andrew Nick as Attorney-in-Fact for Amy E. Herr pursuant to Power of Attorney filed herewith.
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Amy E. Herr filed Form 3 for BIO-TECHNE Corp (TECH) on 07 Feb 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TECH
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,860
- Date
- 01 Feb 2025
- Ownership
- By significant other
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TECH
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2025
- Ownership
- By significant other
- Underlying class
- Common Stock
- Underlying amount
- 3,256
- Exercise price
- $44.33
- Footnotes
- F1
TECH
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2025
- Ownership
- By significant other
- Underlying class
- Common Stock
- Underlying amount
- 6,636
- Exercise price
- $47.60
- Footnotes
- F1
TECH
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2025
- Ownership
- By significant other
- Underlying class
- Common Stock
- Underlying amount
- 4,472
- Exercise price
- $66.97
- Footnotes
- F1
TECH
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2025
- Ownership
- By significant other
- Underlying class
- Common Stock
- Underlying amount
- 2,076
- Exercise price
- $120.46
- Footnotes
- F2
TECH
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2025
- Ownership
- By significant other
- Underlying class
- Common Stock
- Underlying amount
- 2,104
- Exercise price
- $94.52
- Footnotes
- F3
TECH
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2025
- Ownership
- By significant other
- Underlying class
- Common Stock
- Underlying amount
- 1,084
- Exercise price
- $84.61
- Footnotes
- F4
TECH
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2025
- Ownership
- By significant other
- Underlying class
- Common Stock
- Underlying amount
- 1,468
- Exercise price
- $74.91
- Footnotes
- F5
TECH
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2025
- Ownership
- By significant other
- Underlying class
- Common Stock
- Underlying amount
- 237
- Exercise price
- Footnotes
- F6, F7
TECH
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Feb 2025
- Ownership
- By significant other
- Underlying class
- Common Stock
- Underlying amount
- 480
- Exercise price
- Footnotes
- F7, F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 8 footnotes
Footnote F1
Fully vested.
Footnote F2
520 shares vest on each of 8/6/2022, 8/6/2023 and 8/6/2025; and 516 shares vest on 8/6/2024.
Footnote F3
528 shares vest on 8/15/2023 and 8/15/2025; 524 shares vest on 8/15/2024 and 8/15/2026.
Footnote F4
271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.
Footnote F5
367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
Footnote F6
119 restricted stock units vest on 8/15/2025 and 118 restricted stock units vest on 8/15/2026.
Footnote F7
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Footnote F8
160 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027.